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EFFECTS OF LOW-DOSE-GAMMA RAYS ON THE IMMUNE SYSTEM OF 
DIFFERENT ANIMAL MODELS OF DISEASE
Noriko Shimura   Faculty of Pharmaceutical Sciences, Ohu University, Japan
Shuji Kojima   Faculty of Pharmaceutical Sciences, Tokyo University of Science,
Japan
  We reviewed the beneficial or harmful effects of low-dose ionizing radiation on sever-
al diseases based on a search of the literature. The attenuation of autoimmune manifesta-
tions in animal disease models irradiated with low-dose γ-rays was previously reported by
several research groups, whereas the exacerbation of allergic manifestations was described
by others. Based on a detailed examination of the literature, we divided animal disease
models into two groups: one group consisting of collagen-induced arthritis (CIA), exper-
imental encephalomyelitis (EAE), and systemic lupus erythematosus, the pathologies of
which were attenuated by low-dose irradiation, and another group consisting of atopic
dermatitis, asthma, and Hashimoto’s thyroiditis, the pathologies of which were exacerbat-
ed by low-dose irradiation. The same biological indicators, such as cytokine levels and T-
cell subpopulations, were examined in these studies. Low-dose irradiation reduced inter-
feron (IFN)-gamma (γ) and interleukin (IL)-6 levels and increased IL-5 levels and the per-
centage of CD4+CD25+Foxp3+Treg cells in almost all immunological disease cases exam-
ined. Variations in these biological indicators were attributed to the attenuation or exac-
erbation of the disease’s manifestation. We concluded that autoimmune diseases caused
by autoantibodies were attenuated by low-dose irradiation, whereas diseases caused by
antibodies against external antigens, such as atopic dermatitis, were exacerbated.
Keywords: low-dose irradiation, immune response, autoimmune disease, allergic diseases, cytokines, 
T-cell subpopulation
INTRODUCTION
Even very low radiation doses were initially considered to be harmful
until the 1980s, and a linear no-threshold (LNT) dose-response relation-
ship was reported. However, epidemiological studies revealed that the
prevalence of cancer in areas with high natural radiation background was
not high and various animal experiments demonstrated that low-dose
irradiation was not always harmful. Since Luckey first proposed the phys-
iological stimulatory effects of radiation in 1982, much evidence has accu-
mulated in support of this concept. These beneficial and stimulatory
effects, including stimulation of the growth rate (Luckey 1982), enhance-
ment of survival after lethal high-dose irradiation (Yonezawa et al. 1990),
Address correspondence to Noriko Shimura, Faculty of Pharmaceutical Sciences, Ohu
University, 31-1 Misumido, Tomita-machi, Koriyama, Fukushima, 963-8611, Japan; E-mail: 
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prolongation of life span (Ducoff 1975), activation of immune functions
(Liu et al. 1987; Anderson et al. 1988; Liu 1989; Ishii et al. 1995, 1996),
delay in tumor growth or metastasis (Hashimoto et al. 1999; Kojima et al.
2004), delay of death due to radiation-induced acute myeloid leukemia
by an earlier exposure to a small adapting dose of radiation (Mitchel et al.
1999), reducing the risk of both spontaneous spinal osteosarcomas and
lymphomas by a single low-dose and low-dose-rate exposure (Mitchel et al.
2003) in animal experiments, prevention of chemically induced hepato-
toxicity (Kojima et al. 2000b) and prevention of type-I diabetes in NOD
mice (Takahashi et al. 2000), have been referred to as ‘radiation horme-
sis’ (Luckey 1991).
Several studies have since investigated the relationship between low-
dose irradiation and the immune response (Gerber et al. 1983; Liu et al.
1987; Ibuki and Goto 1994). The results obtained from animal experi-
ments demonstrated that low-dose whole-body irradiation enhanced the
immune response by augmenting the proliferative reactive response of T
cells to mitogenic stimulation (Kojima et al. 2000a; Pandey et al. 2005),
altering cytokine release (Liu et al. 2003; Cheda et al. 2008) and immune
cell populations (Ina and Sakai 2005), and/or augmenting T cell activa-
tion capacity by dendritic cells (Shigematsu et al. 2007). Regarding
autoimmunity, the potentiation of T cell-mediated immunity in autoim-
mune-prone mice following exposure to low-dose irradiation was exam-
ined at the end of the 20th century (James and Makinodan 1988; James et
al. 1990), and several research groups subsequently focused on the effects
of low-dose irradiation on autoimmune diseases such as systemic lupus
erythematosus (Ootsuyama et al. 2003; Tanaka et al. 2005; Tago et al.
2008), multiple sclerosis (Tsukimoto et al. 2008), rheumatoid arthritis
(Nakatsukasa et al. 2008, 2010; Weng et al. 2010) and autoimmune thy-
roiditis (Nagayama et al. 2008) after the start of the 21st century.
Some groups have also focused on the effects of low-dose irradiation
on allergic diseases, such as asthma (Fang et al. 2005) and atopic der-
matitis (Fang et al. 2006). These studies originated from the proposal that
low-dose irradiation could alter cytokine levels and the percentage of T
cell subpopulations, which may in turn contribute to the attenuation of
pathologies. If autoimmune reactions can indeed be controlled by low-
dose irradiation, new treatment options may be developed in the future.
Based on the results of the studies described above, we attempted to
focus on the effect of low-dose irradiation on autoimmune diseases and
allergic diseases, classify these effects, and summarize their mechanisms.
Meanwhile, in our referenced papers, whole-body 0.5 Gy/exposure in
animal was considered to be low dose. Many clinical applications con-
cerning low dose radiation therapy (LD-RT) have been reported (Cuttler
2004; Rödel et al. 2012), and most of experimental anti-inflammatory
effects have displayed a maximum between 0.3 Gy and 1.0 Gy. The dose
N. Shimura and S. Kojima
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range seems to be reasonable according to the clinical experience with
LD-RT over more than on century (Kern and Keilholz 2009). Therefore
the authors of our referenced papers might take clinically low dose irra-
diation into consideration because they finally aimed to develop new
therapies for above diseases. Moreover, there are some reports that inves-
tigated the mechanism of LD-RT using the animal models (Hildebrandt
et al. 2000, 2003; Rödel et al. 2007). 0.5 Gy/exposure of γ- or x-ray irradi-
ation was also regarded as low-dose in these animal studies. From above
reasons, we consider 0.5 Gy/ exposure as low-dose irradiation in this
review.
The findings presented in this review will be useful for the develop-
ment of new therapies for immunological disorders.
THE EFFECT OF LOW-DOSE γ-IRRADIATION ON IMMUNE DISEASES
The effect of low-dose ionizing radiation on diseases resulting from
immunological disorders was divided into two groups based on a litera-
ture search: the attenuation and exacerbation of pathologies. Table 1
shows the two types of immunologically related diseases influenced by
low-dose irradiation using animal models. The beneficial effect of low-
dose irradiation has been reported in rheumatoid arthritis (RA), systemic
lupus erythematosus (SLE), and multiple sclerosis (MS), whereas symp-
toms were exacerbated by low-dose irradiation in atopic dermatitis (AD),
asthma, and Hashimoto’s thyroiditis (HT).
Collagen-induced Arthritis (CIA)
Rheumatoid arthritis (RA) is an autoimmune disease that causes
pain, swelling, and stiffness in the joints, and may lead to joint destruc-
tion and chronic disability. It is characterized by the accumulation and
proliferation of inflammatory cells in the synovial lining, synovial over-
growth, and the formation of pannus tissues (Feldmann et al. 1996;
Gravallese 2002; Firestein 2003). As the histopathology and above-men-
tioned clinical features of CIA are similar to those of human RA, CIA is
Effects of low-dose gamma rays on the immune system
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Table 1. Two types of diseases influenced by low-dose irradiation. 
Status Diseases Authors
Attenuation Rheumatoid arthritis Nakatsukasa et al. 2008, 2010; 
of pathology (Collagen-induced arthritis) Weng et al. 2010
Systemic lupus erythematosus Ootsuyama et al. 2003; Tanaka et al. 2005; 
Tago et al. 2008
Multiple sclerosis Tsukimoto et al. 2008
Exacerbation Atopic Dermatitis Fang et al. 2006
of pathology
Asthma Fang et al. 2005; Park et al. 2013b
Hashimoto’s thyroiditis Nagayama et al. 2008
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the most widely used animal model of autoimmunity (Myers et al. 1997).
Several biological indicators of RA have been reported in the living body,
and are the clinical score of pathology, autoantibody concentrations,
cytokine levels, and T cell subpopulations. Autoantibodies, such as
rheumatoid factor and the anti-type II collagen (CII) antibody, play a key
role in the pathogenesis of inflammatory arthritis (Cho et al. 2007; Rowley
et al. 2008). Among the cytokines, tumor necrosis factor-α (TNF-α), inter-
leukin-6 (IL-6) (Chu et al. 1991; Ridderstad et al. 1991), and interleukin-
17 (IL-17) (Nakae et al. 2003; Lubberts et al. 2005; Afzali et al. 2007) have
been closely associated with inflammation in RA. Proper immune func-
tions are strongly dependent on numerical changes in various lympho-
cyte subsets (Askonas 1988). Bogdándi et al. (2010) showed that low-dose
irradiation caused quantitative alterations in these cell numbers.
The schedules for immunization and irradiation are shown in
Figs. 1A, 1B, 1C and 1D. The results of clinical score reported by
Nakatsukasa et al. (2008, 2010) and Weng et al. (2010) are summarized in
Table 2A, and indicated that low-dose irradiation delayed the onset,
reduced the incidence, and attenuated the pathology of CIA in DBA/1J
mice.
Nakatsukasa et al. (2008, 2010) reported that anti-CII antibody pro-
duction was detected in the serum of CIA mice, but not in that of normal
mice, and was suppressed by low-dose irradiation. They also examined
N. Shimura and S. Kojima
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0.5 Gy  (0.96 Gy/min) γ -irradiation 
2821
Immunization with  
CII 
day
6-week-old male DBA/1J 
mice
7 14
Total dose   : 2.5Gy 
FIG. 1A. Schedule for immunization with bovine type II Collagen (CII) and irradiation. (Nakatsukasa
et al. 2008). 
0
0.5 Gy  (0.88 Gy/min) γ -irradiation 
Immunization  
with  CII 
week
6-week-old male DBA/1J 
mice
1 9 Total dose :  
11 weeks  old of age :  3 Gy 
13 weeks old of age : 4 Gy 
15 weeks old of age : 5 Gy 
13 weeks old 
of age 
( developing 
phase) 
5
11 weeks  old 
of age 
( just before 
onset) 
7
15 weeks 
old of age 
( chronic 
phase) 
FIG. 1B. Schedule for immunization with bovine type II Collagen (CII) and irradiation. (Nakatsukasa
et al. 2010). 
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1
0.5 Gy  (0.88 Gy/min) γ -irradiation 
2821
Immunization with  
OVA 
day
6-weeks-old male BALB/c 
mice
7 14
Total dose   : 2.5Gy 
Immunization with  OVA 
0.5 Gy  (0.88 Gy/min) g-irradiation 
Total dose   : 1.5Gy 
day
1 7 14 21 28
6-week-old male BALB/c 
mice (A)  Preirradiation 
( B ) Postirradiation 
FIG. 1C. Schedule for immunization with ovalbumin (OVA) and irradiation. (A) Preirradtiation (B)
Postirradiation (Nakatsukasa et al. 2010). 
1
0.4 Gy  γ -irradiation 
21
Immunization with  
CII 
day
12-week-old male DBA/1 
mice
7 14
Total dose   : 0.4 Gy 
FIG. 1D. Schedule for immunization with bovine type II Collagen (CII) and irradiation. (Weng et al.
2010). 
Table 2A. Changes in the severity of diseases after low-dose irradiation. 
Authors of 
referenced Clinical score 
studies Irradiation (by an established scoring system)
Nakatsukasa 
et al. 2008
Whole-body 0.5Gy/week (0.96Gy/min)
for 5 weeks (from 6w to 10 w old)
Not increased until 50 days after immu-
nization with collagen (almost score 0).
Without irradiation, increased 30-40
days after immunization (above score 2).
Nakatsukasa 
et al. 2010
Whole-body 0.5Gy/week (0.88Gy/min)
for 5 weeks (from 5w to 9 w old)
The severity score was significantly sup-
pressed 6 weeks and 8 weeks after immu-
nization with collagen (score 0.5 for irra-
diated and score 2 for non-irradiated
mice at 6 weeks, score 2.8 for irradiated
and score 4.5 for non-irradiated mice at
8 weeks).
Weng et al. 2010 Whole-body 0.4Gy 24h before a colla-
gen injection
The severity score was less than 2 21 days
after the collagen injection. Most mice
in the CIA control group showed signs
with a severity more than 2.
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tumor necrosis factor levels and cytokines produced by splenocytes of
which spllen was harvested from mice at 3 days after the last irradiation.
Splenocytes from both control and irradiated mice were not stimulated
by any antigen ex vivo and these findings have been summarized in
Table 2B. TNF-α and interferon (IFN)-gamma (γ) levels were high in CIA
mice, but were significantly lower in irradiated CIA mice than in non-irra-
diated CIA mice. They also showed that IL-6 increased in CIA and
decreased to normal levels following treatment with irradiation. Because
IL-6 is known to induce the activation of B cells (Kishimoto 1989), they
also suggested that 0.5Gy γ-irradiation suppressed autoantibody produc-
tion in mice with CIA by suppressing IL-6 production. These results indi-
cate that the anti-CII antibody, which is an autoantibody, and IL-6 play an
important role in developing the pathology of CIA. They concluded that
γ-irradiation suppressed anti-CII antibody levels and the production of IL-
6, thereby contributing to the attenuation of arthritis. From the above
results, they speculated that if γ-irradiation suppressed the production of
any antibodies, including those directed against an external antigen, low-
dose γ-irradiation may be harmful during infection. They then attempted
to examine the effect of repeated 0.5Gy γ-irradiation on antibody pro-
duction against an external antigen. Ovalbumin (OVA) was injected into
BALB/c mice as an external antigen and immunoglobulin levels were
measured during repeated irradiation. The results revealed different
changes in IL-6 concentrations from those in CIA mice. IL-6 production
was significantly increased in the control OVA-immunized group and was
further increased in the irradiated OVA-immunized group. These find-
ings were the reverse of those observed in CIA mice (Tables 2B and 2C),
and indicated that this difference was due to the antigen. CIA has been
attributed to an internal antigen, whereas OVA was an external antigen.
N. Shimura and S. Kojima
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Table 2B. Changes in TNF and cytokine levels in CIA mice with or without irradiation. 
Authors of 
referenced Non-irradiated CIA group Irradiated CIA group versus 
studies TNF and cytokines versus normal group non-irradiated CIA group
↑ : significantly increased ↓ : significantly decreased.
Nakatsukasa
et al. 2008
TNF-α ↑ ↓
IFN-γ ↑ ↓
IL-6 ↑ ↓
Nakatsukasa 
et al. 2010
IL-6 ↑ ↓ (4 and 6 weeks after 
immunization)
→ (8 weeks after 
immunization)
IL-17 ↑ ↓ (4 and 6 weeks after 
immunization)
→ (8 weeks after 
immunization)
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IL-17 levels were significantly increased in the CIA and OVA-immunized
groups, but were significantly decreased by irradiation in both groups
(Tables 2B and 2C). These findings indicated different effects on CIA
and OVA-immunized mice. In CIA mice, the suppression of IL-17 pro-
duction together with the up-regulation of regulatory T (Treg) cell pop-
ulation may contribute to attenuating the pathology of CIA by repeated
0.5-Gy γ irradiation. However, an increase in the production of Th2-type
cytokines, such as IL-10 or IL-6 (Table 2C) together with up-regulation of
the plasma cell percentage (Table 2D), may have contributed to the
enhancement in antibody production in OVA-immunized mice
(Kishimoto 1989; Rousset et al. 1992). Therefore, although IL-17 was sup-
Effects of low-dose gamma rays on the immune system
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Table 2C. Changes in cytokine production by repeated 0.5Gy irradiation in OVA (ovalbumin)-
immunized mice. 
Authors of Non-irradiated OVA Irradiated OVA immunized 
referenced immunized group group versus non-irradiated 
studies Cytokines versus normal group OVA immunized group
Nakatsukasa IL-4 ↑ ↗
et al. 2010 IL-5 → ↗
IL-6 ↑ ↑
IL-10 → ↑
IL-17 ↑ ↓
↑ : significantly increased ↓: significantly decreased → : not significantly different (same level)
↗ : not significant but increasing tendency.
Table 2D. Changes in the percentage (%) of the lymphocyte population by irradiation in OVA-
immunized mice. 
Irradiated OVA 
immunized 
OVA group versus 
Authors of immunized non-irradiated 
referenced group versus OVA immunized Status after 
studies Lymphocytes normal group group irradiation Sampling date
↑ : significantly increased ↓ : significantly decreased → : not significantly different (same level).
Nakatsukasa 
et al. 2010
CD3+ → → Not changed Splenocytes
were obtained 
4 days after
final 
irradiation. 
(10 weeks old)
CD4+ → ↑ Increased 
post-irradiation
CD8+ → ↓ Decreased 
pre-irradiation
CD19+ → → Not changed
CD3–CD19–CD38+
(plasma cell)
↓ ↑ Reduced level
was increased to
normal levels
CD4+CD25+Foxp3+
(Treg cell)
→ ↑ Increased 
pre-irradiation
7
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pressed by irradiation, the effect of antibody production may overcome
that of IL-17.
As for lymphocyte phenotypes in the spleen when
CD4+CD25+Foxp3+T cells were considered as Treg cells, the percentage of
Treg cells was significantly increased by irradiation in these three studies
(Tables 2D and 2E). On the contrary, following irradiation, the absolute
number of total lymphocytes decreased and involved CD4+CD25+Foxp3+
and CD4+FoxP3- T cells (Weng et al, 2010) (Table 2E). They suggested
N. Shimura and S. Kojima
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Table 2E. Changes in the percentage (%) of the lymphocyte population by irradiation. 
Irradiated 
Non-irradiated CIA group 
Authors of CIA group versus 
referenced versus non-irradiated Status after 
studies Lymphocytes normal group CIA group irradiation Sampling date
↑ : significantly increased ↓ : significantly decreased → : not significantly different (same level).
Nakatsukasa 
et al. 2008
CD4+ ↓ → Not changed Splenocytes
were obtained 4
days after the
final irradia-
tion. (10 weeks
old)
CD8+ ↓ → Not changed
CD19+(B cell) → → Not changed
CD3–CD19–CD38+
(plasma cell)
↑ ↓ Reduced to nor-
mal levels
Pan NK+
(NK cell)
↓ → Reduced level
was not
changed by irra-
diation
CD4+CD25+Foxp3+
(Treg cell)
→ ↑ Increased
Nakatsukasa 
et al. 2010
CD4+CD25+Foxp3+
(Treg cell)
→ ↑ Increased Splenocytes
were obtained
4, 6, and 8
weeks after col-
lagen immu-
nization (irradi-
ation was con-
ducted every
week from 3
days before
immunization)
Weng et al. 
2010
Absolute 
number of total
lymphocytes
Not examined ↓ Decreased Peripheral
blood 12 days
or 24 days after
irradiation (col-
lagen injection
was conducted
24 hr after irra-
diation)
Number of
CD4+CD25+Foxp3+
(Treg cell)
Not examined ↓ Decreased
Number of
CD4+Foxp3+
(containing
effector T cells)
Not examined ↓ Decreased
% of Treg cells Not examined ↑ Increased
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that this was because collagen immunization induces lymphocytosis. The
increased proportion of Tregs in the irradiated CIA group as compared
to non-irradiated CIA group (Table 2E) indicated that Tregs were more
resistant in this dose of irradiation and also have a selective advantage in
the homeostatic reconstitution over conventional T cells. The up-regula-
tion of Treg cells appears to be characteristic of these experimental con-
ditions. Some studies have indicated quantitative abnormalities in Treg
cells related to the pathogenesis of CIA (Morgan et al. 2003, 2005). Treg
cells are the main effectors of immunological tolerance and the up-regu-
lation of Treg cells may contribute to attenuating the pathology of CIA.
Systemic lupus erythematosus (SLE)
SLE, which is characterized by spontaneous severe total-body lym-
phadenopathy, hypergammaglobulinemia, autoantibody production, and
immune complex formation, leads to many autoimmune diseases, such as
glomerulonephritis, hepatitis, and inflammation in the blood vessels,
joints, lung, skin, intestine and brain. MRL/MpJ-lpr/lpr (hereafter MRL-
lpr/lpr) mice and MRL/gld mice have generally been used as an animal
model for SLE (Kelley and Roths 1985; Cohen and Eisenberg 1991).
MRL-lpr/lpr mice have a mutation in a cell surface protein, Fas, that
mediates apoptosis (Chu et al. 1993),. Whereas MRL/gld mice develope
a phenotype of autoimmune diseases similar to that of the lpr mice, hav-
ing the mutation within FasL gene (Roths et al. 1984; Watson et al. 1992).
Tanaka et al. (2005) and Tago et al. (2008) examined the effect of repeat-
ed 0.5Gy γ-ray irradiation on autoimmune disease in MRL-lpr/lpr mice.
The schedule for irradiation is shown in Fig. 2A. These researchers
belonged to the same research group; therefore, Tago et al. (2008) took
over unresolved issues from Tanaka et al. (2005). At first, Tanaka et al.
(2005) focused on the kidney and salivary gland, i.e., glomerulonephritis
and sialoadenitis, and showed homological improvements in disease-spe-
cific damage by repeated 0.5Gy γ-ray irradiation. They also demonstrated
that mice with splenomegaly and lymphadenopathy, which were repre-
sentative symptoms in MRL-lpr/lpr mice, recovered and were similar to
normal mice after the last irradiation (0.5Gy each time ; 5 times per week
for 4 weeks) (Tanaka et al. 2005). The abnormal proliferation of
CD3+CD4-CD8-CD45R/B220+ T cells has been observed in MRL-lpr/lpr
Effects of low-dose gamma rays on the immune system
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0
0.5 Gy /day (0.96 Gy/min) γ -irradiation 
week
13-week-old male MRL-lpr/
lpr mice
1 4 2 3
Total dose   : 10 Gy 
FIG. 2A. Schedule for irradiation. (Tanaka et al. 2005, Tago et al. 2008). 
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mice. These cells lack the expression of both CD4 and CD8 and
expressed the CD45R/B220 isoform, which has commonly been
observed on B cells (Budd et al. 1987). This abnormal cell proliferation
has been regarded as the cause of autoimmune manifestation (Cohen
and Eisenberg, 1991). Tanaka et al. (2005) showed a marked increase in
the percentage of CD3+CD4-CD8-CD45R/B220+ T cells, while that of
CD3+CD4+ T cells significantly decreased in MRL-lpr/lpr mice. However,
3 weeks after the last irradiation, the percentage of CD3+CD4-CD8-
CD45R/B220+ T cells harvested from the spleen significantly decreased
and that of CD3+CD4+ T cells recovered to normal levels (Table 3A).
The same results were also reported by Tago et al. (2008). They
demonstrated that the progression of splenomegaly in MRL-lpr/lpr mice
was suppressed (Tago et al. 2008). Since splenomegaly results from an
N. Shimura and S. Kojima
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Table 3A. Changes in the percentage (%) of the lymphocyte population by irradiation. 
Irradiated 
Non-irradiated MRL-lpr/lpr 
Authors of MRL-lpr/lpr group versus 
referenced group versus non-irradiated Status after 
studies Lymphocytes normal group MRL-lpr/lpr group irradiation Sampling date
↑ : significantly increased ↓ : significantly decreased → : not significantly different (same level)
↗ : not significant but increasing tendency ↘ : not significant but decreasing tendency.
Tanaka et al. 
2005
CD3+CD4+ ↓ ↑ Reduced level
was increased
Splenocytes
were obtained 
3 weeks after
last irradiation.
CD3+CD8+ ↓ ↓ Reduced level
was further
slightly
decreased
CD3+CD4–
CD8–B220+
↑ ↓ Markedly
increased level
was decreased
Pan NK+
(NK cell)
↘ ↑ Slightly reduced
level was
increased
Tago et al. 
2008
CD3+CD4–
CD8–B220+
↑ ↓ Increased level
was decreased
at 20 weeks old
Population 
of splenocyte
subsets was
obtained in 
12- to 18-week-
old mice
CD4+ Not examined ↑ Significantly
increased
CD19+ Not examined ↓ Significantly
decreased
CD8+ Not examined → Not changed
Ootsuyama 
et al. 2003
CD4–CD8 ↑
(Non-irradiated
MRL/gld group
versus normal
group)
↓
(Irradiated
MRL/gld group 
versus 
non-irradiated
MRL/gld group)
Markedly
increased level
was decreased
by irradiation
(0.2Gy or 0.5Gy,
5 times/week
for 4 weeks)
Splenocytes
were obtained 
3 days after last
irradiation.
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increase in the number of CD3+CD4-CD8-CD45R/B220+ T cells
(Watanabe-Fukunaga et al. 1992), the suppression of splenomegaly was
due to a reduction in the number of these abnormal cells. They exam-
ined what contributed to this phenomenon, and showed that irradiation
reduced the rate of proliferation of CD3+CD4-CD8-CD45R/B220+ T cells
or induced their death. The results obtained from the quantification of
lactate dehydrogenase (LDH) release indicated that irradiation did not
induce selective CD3+CD4-CD8-CD45R/B220+ T cell death. On the other
hand, by measuring [3H]thymidine incorporation, the rate of prolifera-
tion of CD3+CD4-CD8-CD45R/B220+ T cells was decreased by irradiation,
which suggested that irradiation did not kill cells, but decreased their
proliferation rate.
Regarding kidney damage, Tanaka et al. (2005) focused on NOx pro-
duction in the macrophages of MRL-lpr/lpr mice. NOx was defined as
NO2
-, NO3
-, etc. NOx production may injure the kidney and excessive
NOx was suggested to be regulated by IL-12 (Huang et al. 1996). They
attempted to explain the amelioration of kidney damage, such as
glomerulonephritis, from the lower levels of IL-12 observed following
irradiation (Tanaka et al. 2005). IL-12 production by peritoneal
macrophages was examined in this study, and the results showed that IL-
12 production was significantly lower in mice treated with repeated irra-
diation than in control MRL-lpr/lpr mice (Table 3B). Moreover, signifi-
cantly high NOx
- production in the macrophages of MRL-lpr/lpr mice
was lowered by irradiation in parallel with IL-12. They indicated that a
reduction in IL-12 production led to lower NOx
- production and
improved kidney damage.
Tago et al. (2008) focused on IL-6 because it has been shown to
induce the activation of B cells. They found that the production of IL-6
in splenocytes from irradiated mice was lower than that in disease control
mice. They also measured the production of the anti-single-stranded
DNA antibody in the serum of mice, and found anti-single-stranded DNA
antibody levels were lower in irradiated mice. Anti-single-stranded DNA
antibodies were shown to be pathogenic in the kidney by cross-reaction
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Table 3B. Changes in cytokine levels in MRL-lpr/lpr mice with or without irradiation. 
Authors of Non-irradiated MRL-lpr/lpr Irradiated MRL-lpr/lpr group 
referenced studies Cytokines group versus normal group versus non-irradiated MRL-
lpr/lpr group
Tanaka et al. 2005 IFN-γ ↓ ↓
IL-4 ↓ →
IL-5 ↓ ↑
IL-12 ↓ ↓
↑ : significantly increased ↓ : significantly decreased → : not significantly different (same level).
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with a glomerular antigen (Swanson et al. 1996; Qing et al. 2006). They
indicated that the activation of B cells was suppressed by irradiation
through a decrease in IL-6 levels, followed by the amelioration of kidney
damage after repeated 0.5 Gy γ-irradiation.
On the other hand, Ootsuyama et al. (2003) analyzed the relationship
between changes in the T-cell subpopulation and the amelioration of
autoimmune diseases using MRL/MpTn-gld/gld (MRL/gld mice) as an
animal model. The schedule for irradiation is shown in Fig. 2B. They
examined histological changes in arthritis in knee joints and arthritis in
the kidney. Inflammatory conditions in knee joints and arthritis in the
kidneys were ameliorated after γ-ray irradiation at 0.2 Gy/exposure 5
times per week for 4 weeks. The effect of extended exposure on the com-
position of the splenic T-cell subpopulation was then examined. The
results showed that the abnormal percentage in CD4-CD8- T cells
observed in untreated MRL/gld mice showed a clear decrease after 0.2
Gy or 0.5Gy/exposure 5 times per week for 4 weeks. Furthermore, they
indicated that irradiation-induced apoptosis was specifically observed in
CD4-CD8- T cells and that this phenomenon did not appear to need a Fas-
FasL system. They demonstrated that apoptosis through the Fas-FasL
pathway may hardly occur in response to non-specific stimulus such as
ionizing irradiation.
Ootsuyama et al. (2003) suggested that the CD4-CD8- T cells that accu-
mulated were more sensitive to irradiation than other T-cell subpopula-
tions, and that a decrease in these abnormal cells with extended exposure
to low-dose irradiation led to the amelioration of autoimmune diseases.
Multiple Sclerosis (MS)
Multiple sclerosis (MS) is an autoimmune disease that affects more
than 1 million people worldwide and severely compromises motor and
sensory function. The representative clinical feature of this disease is a
disorder in the central nervous system marked by weakness, numbness, a
loss of muscle coordination, and problems with vision, speech, and blad-
der control. The etiology of this chronic neuroinflammatory disease
N. Shimura and S. Kojima
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week
16-week-old female MRL/
MpTn-gld/gld  mice
1 4 2 3
FIG. 2B. Schedule for irradiation. (Ootsuyama et al. 2003) Radiation dose pattern : (1) 0.05 Gy/day
(0.0013Gy/min) x 5 days/week for 4 weeks (Total dose: 1 Gy); (2) 0.2 Gy/day (1.04Gy/min) x 5
days/week for 4 weeks (Total dose: 4 Gy); (3) 0.5 Gy/day (1.04Gy/min) x 5 days/week for 4 weeks
(Total dose: 10 Gy). 
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remains unknown and there is currently no fully effective treatment
(Lutton et al. 2004; Kipp et al. 2012). Based on histopathological observa-
tions, the penetration of leukocytes into the central nervous system and
clinical symptoms of relapses, remission, and progressive paralysis in MS
have been attributed to the loss of myelin and neurons.
The animal model for MS is experimental autoimmune
encephalomyelitis (EAE) and all current therapies have demonstrated
efficacy in EAE models. EAE is produced by an intradermal injection of a
protein component of central nervous system myelin protein, such as
myelin basic protein (MBP) (Seil 1972; Zamvil et al. 1986).
MS therapy was approached by Tsukimoto et al. (2008) through frac-
tionated low dose γ-ray irradiation. The schedule for immunization and
irradiation is shown in Fig. 3. They investigated therapeutic effects relat-
ed to cytokines, MBP-specific antibodies, and regulatory T-cell by analysis
after irradiation. Previous studies have shown an increase in IL-6 levels in
the serum of MS patients (Stelmasiak et al. 2001; Koutsouraki et al. 2011;
Chen et al. 2012). IL-6 has been implicated in neuroinflammatory reac-
tions and is involved in multiple physiological central nervous system
(CNS) processes such as neuron homeostasis, astrogliogenesis, and neu-
ronal differentiation (Spooren et al. 2011). TNF-α also has a crucial role
in neuroinflammation, and elevated TNF-α levels have been reported in
EAE mice (Haji et al. 2012). Regarding MS patients, TNF-α levels were sig-
nificantly higher in the cerebrospinal fluid (CSF) and in plasma than
those of the controls (Obradović et al. 2012). Moreover, IL-17 and IL-17-
secreting CD4+ T (Th17) cells were shown to play a pivotal role in the
pathogenic mechanism of MS (Aranami and Yamamura 2008). The pro-
portion of Th17 cells in patients with MS was markedly high and serum
IL-17 levels were increased in patients with MS (Wang et al. 2011).
Tsukimoto et al. (2008) showed that the incidence of pathological
changes and the clinical scores of such changes were lower in irradiated
EAE mice than in non-irradiated EAE mice. This result suggests that irra-
diation delays the development of pathology and attenuates pathological
symptoms in EAE mice. The effect of irradiation on the production of
pro-inflammatory cytokines was then examined, and revealed that the
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FIG. 3. Schedule for immunization with myelin basic protein (MBP) and irradiation. (Tsukimoto et
al, 2008). 
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elevated production of TNF-α in EAE mice was slightly suppressed by irra-
diation. However, this slight decrease in TNF-α production may be
involved in the therapeutic effect of repeated 0.5-Gy γ-irradiation on EAE.
In contrast, the higher IL-6 levels in EAE mice were significantly reduced
by irradiation (Table 4). IL-6 induces the activation of B cells; therefore,
the production of autoantibodies involved in the pathology of EAE was
induced by IL-6. In Tsukimoto et al.’s report (2008), IL-6 levels were
reduced by irradiation; therefore, the production of autoantibodies was
suppressed. Anti-MBP antibody levels in the serum of mice were lower in
irradiated EAE mice than in non-irradiated EAE mice. Moreover, the
markedly higher level of IL-17 in EAE mice than in normal mice was also
significantly suppressed by irradiation (Table 4). These results have been
summarized in Table 4. IL-6 has recently been reported to play an impor-
tant role in regulating the balance between IL-17-producing Th17 cells
and Treg cells; therefore, IL-6 may work as a regulator of the Treg/Th17
balance (Kimura and Kishimoto, 2010). When CD4+CD25+Foxp3+ T cells
were considered as Treg cells in Tsukimoto et al.’s study (2008), the per-
centage of Treg cells in the CD4+ T cells of irradiated EAE mice was sig-
nificantly higher than that in the CD4+ T cells of non-irradiated EAE
mice. The increased level of IL-6 in EAE mice was suppressed, which indi-
cated that Th-17 cells and IL-17 were regulated and Treg cells were upreg-
ulated by irradiation. These phenomena may contribute to attenuating
the pathology of EAE.
Atopic dermatitis (AD)
AD is a chronically relapsing inflammatory skin disease with altered
immune responses. The immune system is involved through lymphocyte-
mediated inflammation in the skin, which creates eczema, and the
increased incidence of type I and possibly type IV allergies induced by
environmental allergens (Hanifin 1982; Thestrup-Pedersen 1989).
Elevated IgE and eosinophilia are the representative features of AD
patients and may reflect the increased response of type-2 T-helper (Th2)
cytokines with a decrease in IFN-γ production. IL-4 and IL-5 regulate IgE
synthesis and eosinophil activity in AD, and IL-5 levels, in particular,
N. Shimura and S. Kojima
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Table 4. The effect of irradiation on cytokine levels in EAE mice. 
Authors of Non-irradiated EAE mice Irradiated EAE mice versus 
referenced studies Cytokines versus normal mice non-irradiated EAE mice
Tsukimoto et al. 2008 TNF-α ↗ ↘
IL-6 ↑ ↓
IL-17 ↑ ↓
↑ : significantly increased ↓ : significantly decreased ↘ : not significant but increasing tendenc
↗ : not significant but decreasing tendency.
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appear to change in parallel with the clinical severity; a significant
decrease in IL-5 levels was observed in AD when the clinical severity
decreased (Kondo et al. 2001). Fang et al. (2006) investigated the effect of
repeated small-dose γ-ray irradiation on AD using an animal model. They
attempted to examine whether small-dose γ-ray irradiation was useful for
the treatment of AD because previous reports demonstrated several small
doses of γ-ray irradiation inhibited xenograft tumor growth in mice
(Kojima et al. 2002, 2004). These anti-tumor effects were mediated by
radiation-induced elevations in the IFN-γ / IL-4 (type1- helper (Th-1)
cytokine / Th-2 cytokine) ratio. Fang et al. (2006) considered that such
cytokine polarization may also contribute to the treatment of AD.
NC/Nga mice, which were established as an inbred strain by Kondo in
1957 based on Japanese fancy mice, were shown to be suitable as an ani-
mal model of AD (Kondo et al. 1969; Festing 1996), and were subse-
quently treated with a mite antigen. This animal model was shown to
manifest clinical and immunological aspects similar to patients with AD
(Sasakawa et al. 2001).
Fang et al. (2006) attempted to induce AD models in NC/Nga mice,
which were irradiated with 0.5 Gy of γ-rays 2 days before each stimulation
with the mite antigen, twice a week from the age of 7 to 11 weeks old
(total 10 times) (Fig. 4). Assays of total IgE and cytokine production by
spleen lymphocytes were performed and flow cytometric analysis was con-
ducted on the subpopulations of spleen lymphocytes. The total IgE level
in the AD disease-control group increased after the 3rd stimulation with
the mite antigen, reached a plateau at around the 5th stimulation, and
remained significantly higher until the 10th stimulation. The irradiated
group showed significantly higher IgE values than the disease-control
group at each point after the 3rd stimulation. This result suggested that B
cells were stimulated by repeated small-dose irradiation. Regarding
cytokines, IL-5 levels in the disease-control group of NC/Nga mice sig-
nificantly increased to 20 times higher than those in the normal group,
and these levels increased further by irradiation to approximately 1.5
times higher than those in the disease-control group. Increasing IL-5 lev-
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FIG. 4. Schedule for injection with mite antigen and irradiation. (Fang et al. 2006). 
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els may result in the severe pathologies of AD, as described above. IFN-γ
levels were lower in irradiation-treated group than in the disease-control
group (Table 5A). Therefore, the ratio of IFN-γ/IL-4 in the disease-con-
trol group of NC/Nga mice was significantly lower than that in the non-
stimulated normal group, and this ratio was significantly reduced by irra-
diation. The subpopulation of spleen lymphocytes was examined and
slightly lower percentages of CD3+, CD3+CD4+ and CD3+CD8+ T cells were
observed in the disease control group, and the percentage of CD3+, and
CD3+CD4+ was significantly higher in the irradiation-treated group than
in the disease control group (Table 5B). An increase in the percentage of
CD19+ cells was only seen in the disease-control group, and this increase
was inhibited by irradiation (Table 5B).
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Table 5A. The effect of irradiation on cytokine levels in atopic dermatitis in NC/Nga mice. 
Non-irradiated atopic Irradiated AD mice 
Authors of dermatitis (AD)control versus non-irradiated 
referenced studies Cytokines mice versus normal mice AD control mice
Fang et al. 2006 IL-4 ↗ ↗
IL-5 ↑ ↑
IFN-γ ↓ ↘
↑ : significantly increased ↓ : significantly decreased → : not significantly different (same level)
↗ : not significant but increasing tenden ↘ : not significant but decreasing tendency.
Table 5B. Changes in the percentage (%) of the lymphocyte population by irradiation in NC/Nga
mice. 
Irradiated 
Non-irradiated AD mice 
Authors of AD mice group versus 
referenced group versus non-irradiated Status after 
studies Lymphocytes normal mice AD mice group irradiation Sampling date
↑: significantly increased ↓ : significantly decreased → : not significantly different (same level).
Fang et al. 
2006
CD3+ ↓ ↑ Significantly
higher than the
disease control
Splenocytes
were obtained
24 hr after the
last stimulation
(11 weeks 
of age)
CD3+CD4+ → ↑ Significantly
higher than the
disease control
CD3+CD8+ → → Not changed
CD19 + ↑ ↓ Increased level
was reduced
Pan-NK +cell → → Not changed
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They concluded that repeated low-dose ionizing radiation may exac-
erbate the immune response in AD, which is an immune hypersensitivity
disease.
Asthma
Asthma is characterized by inflammation, reversible airway obstruc-
tion, increased airway responsiveness to various stimuli, and the produc-
tion of a large quantity of IgE antibodies by B cells and a decrease in the
IFN-γ/IL-4 ratio (Okudaira et al. 1983; Nawata et al. 1984; Goldstein et al.
1994). Fang et al. (2005) attempted to examine the effect of γ-ray irradia-
tion on asthma using an animal model because the immuno-modulatory
effects of whole-body γ-ray irradiation may act in opposition to the path-
ogenic mechanism of asthma. They used a murine model of asthma,
namely, BALB/c mice that were sensitized and challenged with ovalbu-
min (OVA) (Krinzman et al. 1996; Ikeda et al. 2002). The schedule for sen-
sitization and challenge with OVA and irradiation is shown in Fig. 5A.
Total IgE content, cytokine levels, and the lymphocyte subpopulation
were examined in the murine asthma model. The total IgE content in
OVA-induced asthmatic mice significantly increased and reached a maxi-
mum level approximately 30 days after the start of the experiment. When
the effect of 10 repeats of 0.5Gy γ-ray irradiation on total IgE levels was
examined in OVA-induced asthma model mice on day 24, the value of the
irradiated group was approximately two times higher than that of the dis-
ease control group. Many previous studies have demonstrated that the
allergic inflammation associated with asthma is due to T-lymphocyte acti-
vation with the predominant production of IL-4 and IL-5 (Krug et al.
1996; Park et al. 1996; Humbert et al. 1997). The production of IL-4 and
IL-5 in the asthma disease-control group was significantly higher than
that in the non-sensitized normal-group in a study by Fang et al. (2005).
These cytokine levels were also significantly higher in the irradiated
group than in the disease-control group. When 0.5 Gy γ-ray irradiation
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2015
OVA sensitization 
Intraperitoneal  injection  
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FIG. 5A. Schedule for sensitization and challenge with OVA and irradiation. (Fang et al. 2005). 
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was repeated 10 times, both of these cytokines increased further
(Table 6A). IFN-γ levels in the disease-control group were also signifi-
cantly higher than those in the non-sensitized group; however, these lev-
els were reduced to normal values following irradiation (Table 6A).
Therefore the IFN-γ /IL-4 ratio of the irradiated group was markedly
reduced, which suggested the exacerbation of asthma. The effect of
repeated 0.5 Gy γ -ray irradiation on the percentage change in the lym-
phocyte subpopulation was then examined in asthmatic mice. The per-
centages of CD3+, CD4+, and CD8+ T cells after treatment with OVA were
significantly lower than those in the normal group, whereas those of
CD19+ and Pan-NK were slightly increased compared with the normal
group, however, the increase in percentages of these cells were not sig-
nificant (Table 6B). As a whole, the percentage of T cells could be regard-
ed as decreasing. There is a report that asthmatic patients showed a sta-
tistically significant increase in CD4+ cells in blood (Mota-Pinto et al.
2011), however, there are few reports that examined the absolute number
of T cells in other organs. Therefore the decreased percentage of T cells
in spleen cannot be known where they are going. The statistical differ-
ence between before and after treatment was so small that the changes of
N. Shimura and S. Kojima
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Table 6A. The effect of irradiation on cytokine levels in asthma model mice. 
Authors of Non-irradiated asthma Irradiated asthma mice versus 
referenced studies Cytokines mice versus normal mice non-irradiated asthma mice
Fang et al. 2005 IL-4 ↑ ↑
IL-5 ↑ ↑
IFN-γ ↑ ↓
(Reduced to normal levels)
↑ : significantly increased ↓ : significantly decreased → : not significantly different (same level).
Table 6B. Changes in the percentage (%) of the lymphocyte population by irradiation in asthma
model mice. 
Non-irradiated Irradiated asthma 
Authors of asthma mice mice versus 
referenced versus non-irradiated Status after 
studies Lymphocytes normal mice asthma mice irradiation Sampling date
↑ : significantly increased ↓ : significantly decreased → : not significantly different (same level)
↗ : not significant but increasing tendency ↘ : not significant but decreasing tendency.
Fang et al. 
2005
CD3+ ↓ ↑ Increased (to
normal levels)
Splenocytes
were obtained
24 hr after the
final inhalation
on day 23.
CD4+ ↓ ↑ Increased (to
normal levels)
CD8+ ↓ → Not changed
CD19+ ↗ ↓ Decreased
Pan-NK cell ↗ → Not changed
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T cell numbers in other organs might not be detected. These decreases
in the percentages of CD3+ and CD4+ T cells were blocked by irradiation.
The percentages of CD8+ T cells and Pan-NK were almost the same fol-
lowing irradiation, while that of CD19+ T cells was decreased significantly
in comparison with that in the disease-control group. The activation, dif-
ferentiation and multiplication of T helper cells (CD3+CD4+) play a cen-
tral roles in the immune enhancement (Lara-Marquez et al. 1998, 2001;
Robinson et al. 1992). The increased percentage of CD3+CD4+ after irra-
diation might have relation to the above immune enhancement.
From the above results, it was concluded that repeated γ-ray irradia-
tion may exacerbate asthma.
A recent study (Park et al. 2013b) showed similar results to those of
Fang et al. (2005) . Park et al. (2013b) demonstrated that fractionated irra-
diation induced chronic allergic airway inflammation; therefore, irradia-
tion resulted in the exacerbation of asthma. They irradiated C57BL/6
mice repeatedly at 1 or 0.5Gy for 6 months and, following irradiation,
sensitized and challenged these mice with OVA over a short period of
time (Fig. 5B). In their irradiation protocol, sensitization and the chal-
lenge were performed following irradiation, and not at the same time. In
Fang et al. (2005)’s protocol, the first sensitization was performed 3 days
after the first 0.5Gy irradiation, following which sensitization and the
challenge were simultaneously or alternately conducted with irradiation.
The protocol used by Park et al. (2013b) (Fig. 5B) was not completely the
same as that of Fang et al. (2005) (Fig. 5A)., however, both had the same
starting point. The two research groups started from irradiation, after
which they sensitized mice.
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FIG. 5B. Schedule for sensitization and challenge with OVA and irradiation. (Park et al. 2013b). 
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Park et al. (2013b) concluded that fractionated irradiation induced
chronic allergic airway inflammation through increasing macrophages
infiltration into the lung and production of active TGF-β.
Hashimoto’s thyroiditis (HT)
Hashimoto’s disease was first introduced as struma lymphomatosa, a
disease of the thyroid gland, by Hashimoto in 1912 (Hashimoto 1912).
Hashimoto’s thyroiditis (HT) is characterized by destruction of the thy-
roid gland by the cellular immune response and consequent hypothy-
roidism. The thyroid glands were shown to be enlarged in a symmetrical
fashion and the degree of enlargement was not ascertainable from a
pathological examination alone. Microscopically, typical cases showed fol-
licles greatly diminished in size and lined with highly eosinophilic epithe-
lia (Marshall and Meissner 1955). Lymphocytic infiltration and degener-
ative changes in follicular epithelia have also been reported (Biörklund
and Söderström 1976; Sato et al. 1977). HT is considered to be an autoim-
mune disease and previous studies examined thyroid-related autoanti-
bodies (Jasani et al. 1999; Nakamura et al. 2008). As significant correla-
tions between irradiation and thyroid autoimmunity were observed in
studies conducted at Chernobyl (Vykhovanets et al. 1997; Pacini et al.
1998), Nagayama et al. (2008) attempted to evaluate how irradiation
affected thyroid autoimmunity in a mouse model. They used a sponta-
neous model of non-obese diabetic-H2h4 (NOD-H2h4) mice for HT, which
develop antithyrogloblin autoantibodies and intrathyroidal lymphocyte
infiltration when supplied with iodine in their drinking water (Many et al.
1996; Rasooly et al. 1996). The schedule for irradiation is shown in Fig. 6.
Nagayama et al. (2008) evaluated the effect of irradiation on the histology
of the thyroid gland. Although naive mice showed little intrathyroidal
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FIG. 6. Schedule for irradiation. (Nagayama et al. 2008). 
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lymphocyte infiltration, NaI-treated mice developed mild to severe thy-
roiditis. These results indicated that the development of thyroiditis was
accompanied by the appearance of anti-Tg autoantibodies in the sera.
Their irradiation protocol was divided into 2 arms, one was single dose
irradiation (0.05, 0.5 or 3 Gy/mouse) and the other was fractionated
(0.05 Gy twice a week or 0.5 Gy once a week for nine weeks) doses of γ-
irradiation. As a result of irradiation, a single dose of whole-body irradia-
tion with 0.5 Gy one week prior to the beginning of NaI significantly
enhanced the severity of thyroiditis and titers of anti-Tg autoantibodies.
However, non of other irradiation protocols that are shown in Fig. 6 did
not affect the degree of thyroiditis or titers of anti-Tg autoantibodies.
They also examined whether an adaptive response was observed in this
model, namely, whether the induction of radioresistance to subsequent
higher doses of radiation occurred by pretreatment with low radiation
doses. The results obtained revealed that thyroiditis was enhanced in all
groups of mice that received 0.5 Gy whole-body irradiation with or with-
out pretreatment with a very low dose (0.05 Gy) of irradiation one or two
weeks before, and demonstrated the lack of an adaptive response.
Regarding the effect of irradiation on immune cells (splenocytes), they
examined the total number of spleen cells, CD4+ T cells, CD8+ T cells,
CD19+ B cells, CD4+CD25+ T cells, and CD4+Foxp3+ T cells. A single dose
of whole-body irradiation with 0.05Gy or 0.5 Gy had little effect on the
number of spleen cells, except for a slight decrease of approximately 30%
in the number of splenocytes with 0.5 Gy irradiation. The above results
demonstrated that low-dose irradiation exacerbated thyroid autoimmu-
nity in NOD-H2h4 mice, as demonstrated by elevated thyroiditis scores
and anti-Tg autoantibody titers.
They also studied the irradiation effect on the pathology of Grave’s
disease, which represented hyperthyroidism caused by the production of
excessive hormones; however, no effect was observed in the Grave’s dis-
ease animal model.
DISCUSSION
As described above, the effect of low-dose ionizing radiation on
immunological diseases was divided into two groups; the attenuation and
exacerbation of pathology. The pathologies of RA, SLE, and MS were
attenuated by low-dose irradiation, whereas, the pathologies of AD, asth-
ma, and HT were exacerbated by low-dose irradiation.
The effect of low-dose irradiation was evaluated on diseases caused by
immunological disorders in our literature search by four biological indi-
cators: the severity of pathologies, cytokine levels, autoantibody produc-
tion, and T-cell subpopulations, which changed according to the pro-
gression of pathologies and, therefore, played important roles in evaluat-
ing these diseases.
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Diseases in which pathological improvements are expected with low-dose
irradiation.
Severity of pathologies
The pathological severity of CIA, the pathology of which resembled
that of human RA, was examined using an established scoring system
(Inglis et al. 2007). As shown in Table 2A, Nakatsukasa et al. (2008) report-
ed that the severity score of arthritis in irradiated CIA mice did not
increase until 50 days after immunization with collagen, whereas the
score increased 30 to 40 days after immunization without irradiation.
They also indicated that the incidence of CIA was reduced by irradiation.
A detailed examination of pathological changes was conducted 4, 6, and
8 weeks after immunization in their 2010 report. These time points of
examination corresponded to the pathological stages of just before the
onset, the developing phase, and the chronic phase of CIA, respectively.
They indicated that the severity score was significantly suppressed 6 weeks
and 8 weeks after immunization with collagen; therefore, low-dose irradi-
ation was considered to be effective before the chronic stage of this dis-
ease. An effective result was obtained in Weng et al.’s study (2010), even
though irradiation was administered just once before the collagen injec-
tion. They demonstrated that most mice in the CIA control group showed
signs of arthritis, with a severity score equal or more than 2, 21 days after
immunization with collagen, while all mice in the irradiated group scored
less than 2. Based on the results of these three studies, the beneficial
effect of low-dose irradiation appears to have been observed in a rela-
tively earlier phase of the disease. When irradiation was administered
once, its effect appeared to have been maintained for 3 weeks after immu-
nization with collagen. On the other hand, the beneficial effect of repeat-
ed low-dose irradiation appears to have lasted for 8 weeks after immu-
nization; however, no significant effect was reported after 8 weeks.
As for SLE, Tanaka et al. (2005) showed photomicrographs of tissue
sections including the kidney or salivary gland of MRL-+/+ and MRL-
lpr/lpr mice. From their results, non-irradiated MRL-lpr/lpr mice exhib-
ited severe histological damage to the kidney or salivary gland; however,
this damage was markedly suppressed by repeated low-dose irradiation.
These findings were not evaluated by an established scoring system, but
by the clearly attenuated changes observed in tissue sections.
Tsukimoto et al. (2008) evaluated EAE pathology by clinical score
based on the degree of paralysis. They indicated that the severity of EAE
was attenuated by low-dose irradiation .
Cytokine levels
The profile of cytokine secretion reflects the functional integrity of
the immune system because cytokines are the most important mediators
by which cells of the immune system communicate.
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Many studies have investigated the the relationship between IL-6 and
RA because IL-6 plays a key role in the local and systemic manifestation
of RA. IL-6 concentrations were higher in the synovial fluid (Westacott et
al. 1990; Harigai et al. 1991; Ridderstad et al. 1991) and serum (Spirchez
et al. 2012) of patients with RA, and quantitative analysis of IL-6 cytokine
gene expression in RA by in situ hybridization of synovial fluid cells
(Firestein et al. 1990; Tan et al. 1990) supported these findings. IL-6 is not
only a proinflammatory cytokine, but may also interact in complex ways
with cells involved in bone remodeling. Abdel Meguid et al. (2013) indi-
cated that IL-6 played an important role in increasing osteoclastic activi-
ty and subsequent bone resorption in patients with RA, and suggested
that blocking IL-6 with IL-6 inhibitors may be effective in inhibiting the
inflammatory process and preventing the bone complications associated
with RA diseases. Table 2B shows that IL-6 levels were significantly higher
in the non-irradiated CIA mice group than those in the normal mice
group. However, these levels were significantly reduced after repeated
low-dose irradiation. Changes in the concentration of IL-6 have been
used to as evidence for the attenuation observed in histological examina-
tions. On the other hand, because no change in IL-6 was observed 8
weeks after immunization, the beneficial effect of repeated low-dose irra-
diation appears to occur in the earlier phase of the disease. This corre-
lated well with the evaluation by clinical score. TNF-α levels were also sig-
nificantly higher in the non-irradiated CIA mice group than in the nor-
mal mice group, and significantly decreased following irradiation (Table
2B). TNF-α was shown to be localized in the inflamed synovial tissue of
patients with RA (Chu et al. 1991), is involved in the cytokine network in
RA, and contributes to IL-6 production by synovial fibroblasts in vivo
(Harigai et al. 1991). In our literature search, we found that TNF-α levels
significantly increased in the non-irradiated CIA mice group, but signifi-
cantly decreased after irradiation. This phenomenon was similar to the
changes observed in IL-6 levels. Therefore, changes in TNF-α levels may
contribute to those in IL-6 level (Table 2B).
According to the report by Tsukimoto et al. (2008), the increase in 
IL-6 levels in EAE mice was significantly reduced by irradiation (Table 4).
This was the same pattern of change as that observed in CIA. Moreover,
IL-17 levels also increased in non-irradiated EAE mice and significantly
decreased with irradiation. A previous study demonstrated that IL-17
increased IL-6 release; therefore, IL-6 may behave in a similar manner to
that of IL-17 (Wang et al. 2008a). IL-17 showed similar behavior that of 
IL-6 in CIA (Table 2B). The effect of low-dose irradiation on interleukin
levels in CIA and EAE were similar (Table 2B and Table 4). However, the
levels of interleukins observed in OVA-immunized mice were different
from those in CIA or EAE mice. IL-6 production was significantly higher
in non-irradiated OVA-immunized mice than in non-immunized mice,
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and a further increase was reported in the irradiated group (Table 2C).
Since IL-6 is known to induce the activation of B cells, leading to the pro-
duction of antibodies by plasma cells (Kishimoto 1989), an enhancement
in antibody production occurred in irradiated OVA-immunized mice.
Nakatsukasa reported that a further significant increase in IgG produc-
tion was observed in pre-irradiated OVA-immunized mice and slight
increases were observed in IgE production. On the other hand, produc-
tion of the anti-CII autoantibody was reported to be lower in irradiated
mice with CIA than in non-irradiated mice (Nakatsukasa et al. 2008,
2010). The suppression of IL-6 production by low-dose irradiation may
contribute to the suppression of anti-CII autoantibody production
because IL-6 levels were significantly lower in irradiated CIA mice than in
non-irradiated CIA mice (Table 2B). IL-6 levels were shown to be closely
related with antibody production; however, differences existed depend-
ing on whether the antigen was external or internal. OVA is an external
antigen, whereas CII is considered to be internal antigen. They indicated
that 0.5Gy irradiation enhances antibody production in response to an
external antigen, and could exacerbate the pathology of the disease.
However, attenuation of the disease pathology may be expected when the
disease is caused by an autoantibody against an internal antigen.
Anti-MBP antibody levels were measured in the serum of EAE mice
because this was regarded as a pathogenic autoantibody produced by acti-
vated B cells. Tsukimoto et al. (2008) indicated that anti-MBP antibody
levels were lower in irradiated EAE mice than in non-irradiated EAE
mice. Since the anti-MBP antibody is an antibody against an internal anti-
gen, attenuation of the disease pathology could also be expected in EAE,
similar to that in CIA.
T-cell subpopulations
Proper immune functions are dependent on the presence of a critical
number of cells. The effects of low-dose irradiation on the immune sys-
tem were examined by determining time-dependent numerical changes
in various lymphocyte subsets (Bogdándi et al. 2010). Bogdándi et al. par-
ticularly reported the numerical changes of CD4+CD25+Foxp3+ Treg cells,
following low-dose irradiation in C57BL/6 mice. Nakatsukasa et al. (2008;
2010) and Weng et al. (2010) also reported the percentages of these cells
were significantly higher in irradiated CIA mice and irradiated OVA-
immunized mice (Tables 2D and 2E). The up-regulation of Treg cells in
irradiated mice was also reported in MRL-lpr/lpr mice, used as an animal
model for SLE (Tago et al. 2008), and EAE mice, used as an animal model
for MS (Tsukimoto et al. 2008). On the other hand, Bogdándi et al. (2010)
reported no significant change in the percentage of CD4+CD25+Foxp3+
Treg cells in normal C57BL/6 mice after one single 0.5Gy γ-irradiation.
A difference may exist between normal mice and disease mouse models.
The up-regulation of Treg cells after low-dose irradiation was observed in
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all mouse models of autoimmune diseases from our referenced studies.
The up-regulation of Treg cells after low-dose irradiation may be a com-
mon event in autoimmune disease mouse models. Treg cells are crucial
mediators of autoimmune tolerance, and a deficiency or dysfunction in
these cells may contribute to the development of autoimmune diseases
(Sakaguchi 2005; Liu and Leung 2006). However, expansion of the Treg
cell population could also prevent autoimmune attacks in these diseases
(Viglietta et al. 2004; Matarese et al. 2005). Tregs regulate ongoing
immune responses under normal conditions and prevent autoimmunity,
imbalanced function or number of these Tregs, and can lead to
decreased autoimmunity (Cools et al. 2007). The suppressive function of
CD4+CD25+Tregs was lower in patients with autoimmune diseases such as
MS or RA than healthy donors (Viglietta et al. 2004; Anderson and Isaacs
2008). In addition, some autoimmune diseases were shown to have
reduced levels of CD4+CD25+Tregs in the peripheral blood (Longhi et al.
2006). Although the population of CD4+CD25+Foxp3+ Treg cells in the
disease mice of CIA (Table 2E) or EAE (Tsukimoto et al. 2008) was not
significantly lower than that in normal mice with irradiation, the up-reg-
ulation of Treg cells reported in the low-dose irradiated disease mice of
our referenced studies may have contributed to the control of autoim-
munity and attenuation of pathologies. The application of a physiological
regulatory system could be a rational strategy to treat autoimmune dis-
eases. Several reports have demonstrated Treg cell expansion using some
drugs (Wang et al. 2008b; Wekerie 2008; Daniel et al. 2010; Asanuma et al.
2011). If Treg populations are controlled by repeated low-dose irradia-
tion, the same treatment effect may be obtained without using drugs.
Repeated low-dose irradiation may be effective and a good treatment
strategy for some patients, especially those with allergies to such drugs or
decreased liver and kidney functions.
Meanwhile, total doses irradiated to CIA mice were 2.5 Gy-5 Gy in
Nakatsukasa et al.’s reports (2008, 2010) (Figs. 1A, 1B and 1C) and 0.4 Gy
in Weng et al.’s report (2010) (Fig. 1D). These levels were within the limit
of the clinical application’s levels which have been established empirical-
ly. Namely, these were single doses of 0.3-1.0 Gy in 4-5 fractions for acute
and 1-3 fractions for chronic diseases per week to total doses of 3-5 Gy and
12 Gy, respectively (Seegenschmiedt et al, 1997). In animal studies, there
are reports that indicated the anti-inflammatory effect and the reduction
of clinical symptoms if the local irradiations were given with daily frac-
tionated doses of 5 x0.5 Gy, total dose was 2.5 Gy (Hildebrandt et al, 2000,
2003). In Nakatsukasa et al.’s reports (2008, 2010), the whole body irra-
diation was conducted, therefore somewhat higher doses than that of
local irradiation might be applied. In the report of SLE, total irradiation
doses were within the limit of 10 Gy (Ootsuyama et al, 2003, Tago et al,
2008, Tanaka et al, 2005) (Figs. 1A and 1B). It seems to be somewhat high-
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er but within the limit of clinical application’s levels (Seegenschmiedt et
al, 1997). Total irradiation doses in CIA, SLE and EAE were considered
to be appropriate to examine the effect of low dose irradiation on inflam-
matory diseases.
Diseases in which pathological exacerbation is expected with low-dose
irradiation.
The pathological severity of AD and asthma were not evaluated by his-
tological examinations in our referenced three studies (Fang et al. 2005,
2006; Nagayama et al. 2008). They evaluated pathological exacerbation
following low-dose irradiation based on cytokine levels and T-cell sub-
populations. On the other hand, although HT was evaluated by histolog-
ical examinations using severity scores, cytokine levels were not meas-
ured. Regarding HT, the severity score, anti-Tg antibody levels, and T-cell
subpopulation were examined to evaluate pathological changes.
Cytokine levels
AD is characterized by elevated serum IgE levels and expression of
the cytokines IL-4, IL-5, and IFN-γ (Leung 1993; Spergel et al. 1999). The
synthesis of IgE was shown to be regulated by IL-4, IFN-γ, and IL-2. IL-4
enhanced the production of IgE, whereas IFN-γ inhibited IL-4-mediated
IgE production (Takahashi et al. 1992). The mechanisms by which IgE
synthesis was increased in AD may be related to either increased IL-4 pro-
duction and/or decreased IFN-γ (Jujo et al. 1992; Nakazawa et al. 1997).
On the other hand, AD skin lesions have been shown to express IL-5
mRNA and protein (Tanaka et al. 1994), and IL-5 also regulates IgE syn-
thesis and promotes eosinophil development (Leung 1998). From these
studies, Fang et al. (2006) attempted to determine time-dependent
changes in total IgE and IL-4, IL-5, and IFN-γ levels produced by spleen
lymphocytes with or without low-dose irradiation. As a result, the slightly
increased level of IL-4 in disease control NC/Nga mice was also further
increased after low-dose irradiation (Table 5A). The difference in IL-4
levels was slight; however, significantly increased IL-5 levels were observed
in disease control mice, and these levels were significantly higher in irra-
diation-treated disease mice than in disease control mice. On the other
hand, IFN-γ levels in the disease control group of NC/Nga mice were sig-
nificantly lower than those in the normal group, and irradiation further
lowered these levels (Table 5A). IgE levels were shown to increase con-
comitantly with changes in cytokine levels; therefore, they concluded that
low-dose irradiation exacerbated the pathology of AD. IgE plays an
important role in allergies, acting as an initiating factor, and is involved
in its persistence and exacerbation. Although they did not perform
pathological examinations, such as scoring, they concluded that IgE and
cytokine levels were reliable.
N. Shimura and S. Kojima
454
26
Dose-Response: An International Journal, Vol. 12 [2014], Iss. 3, Art. 8
https://scholarworks.umass.edu/dose_response/vol12/iss3/8
Several studies were undertaken to examine which cytokine was
involved in the pathogenesis of asthma. IL-4, IL-5, IL-6, TNF-α, and IFN-
γ are considered to play pivotal roles in the pathological characteristics of
asthma, which has been attributed to the presence of inflammatory cell
infiltrates in the bronchial mucosa consisting of activated mast cells,
eosinophils, and T-cells (Bradding et al. 1994; Tang et al. 1995; Möller et
al. 1996; Nagai et al. 1996). IL-4 and IL-5, in particular, have been shown
to play important roles in IgE production and eosinophilia. IL-4 is essen-
tial for IgE production, and IL-5 is a major factor involved in the pro-
duction and activation of eosinophils (Sewell and Mu 1996). For exam-
ple, IL-4 deficient mice had less eosinophils in the bronchoalveolar
lavage fluid and markedly reduced peribronchial inflammation than that
in wild type mice after immunization with aerosolized OVA (Brusselle et
al. 1994). IL-4 knockout mice were also unable to develop allergic
eosinophilic airway infiltration and did not produce specific IgE anti-
bodies (Pauwels et al. 1997). A previous study demonstrated that anti-IL-
4 inhibited IgE production in a murine model of atopic asthma and indi-
cated anti-IL-4 may be a prophylactic agent for asthma (Zhou et al. 1997).
Eosinophilia, lung damage, and airway hyperreactivity normally resulting
from an aeroallergen challenge were abolished in IL-5-deficient mice
(Foster et al. 1996). IL-5 is considered to be one of the central mediators
in the pathogenesis of allergic asthma. On the other hand, IFN-γ was
shown to inhibit eosinophil infiltration by inhibiting the production of
IL-5 in a mouse model (Shi et al. 1996). They indicated that IFN-γ may be
important in the treatment of asthma. Fang et al. (2005) attempted to
measure the levels of IL-4, IL-5, and IFN-γ produced by spleen lympho-
cytes. The production of IL-4 and IL-5 in the disease-control group was
significantly higher than that in the non-sensitized normal group. These
cytokine levels in the irradiated group were significantly higher than
those in the disease-control-group. IFN-γ levels in the disease-control
group were also significantly higher than those in the non-sensitized
group; however, γ-ray irradiation clearly lowered these elevated levels to
normal values (Table 6A). Considering the change in cytokine levels,
repeated irradiation with γ-rays may exacerbate the pathology of asthma
because the studies described above demonstrated the roles of these
cytokines in asthma. Fang et al. (2005) reported the exacerbation of asth-
ma based on changes in the levels of these cytokines. The same result was
obtained in Park et al.’s report (2013b). They measured IFN-γ, IL-4, and
IL-17 levels as representative cytokines in the inflammatory site, and
showed that IFN-γ levels in the bronchoalveolar lavage fluid (BALF) of
irradiated mice was lower than that of non-irradiated mice. Moreover, IL-
4 levels in the BALF of irradiated mice significantly increased in the
group exposed to 5Gy split into 0.5Gy. IL-17 levels were also significantly
higher than those of non-irradiated mice. They attributed this exacerba-
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tion in the pathology of asthma to the higher level of IL-4 in irradiated
mice because IL-4 preferentially induces switching to IgG1 and IgE. They
also indicated that fractionated irradiation induced chronic allergic air-
way inflammation by increasing the influx of macrophages and activating
transforming growth factor (TGF)-β levels.
T-cell subpopulations
The influence of irradiation on subpopulations of spleen lymphocytes
was examined by Fang et al. (2005, 2006) in AD and asthma model mice.
Similar results were obtained in both pathologies. The percentage of CD3+
cells was significantly lower in AD mice than in normal mice, while that of
CD19+ was higher than that in normal mice. After irradiation with γ-rays,
the percentages of CD3+ and CD4+ cells were significantly higher than
those in the disease group, whereas those of CD8+ T cells and Pan-NK
remained unchanged. The percentage of CD19+ was significantly lower
than that in the disease-control group (Table 5B). Lower percentages of
CD3+, CD3+CD4+, and CD3+CD8+ T cells were observed in asthma model
mice, and irradiation increased these percentages. The percentage of
CD19+ was increased in disease mice, and this level was significantly
reduced following irradiation (Table 6B). Similar findings were observed
for changes in the T-cell subpopulation before and after irradiation in AD
and asthma. These results indicate that irradiation may activate T cell-
polarization to helper cells (CD3+CD4+). Since AD and asthma are char-
acterized by the production of large quantities of IgE antibodies by B cells,
the increased percentage of CD4+ T cells, which help B cells produce anti-
bodies, may contribute to the exacerbation of these pathologies.
Regarding HT, although the number of splenocytes slightly decreased
after a single dose of whole-body γ-irradiation with 0.5Gy, no significant
changes were observed in the percentages of T-cell subpopulations.
Nagayama et al.(2008) showed that a single dose of whole-body γ-irradia-
tion with 0.5Gy one week prior to beginning NaI significantly enhanced
the severity of thyroiditis and titers of anti-Tg autoantibodies. They con-
cluded that low-dose irradiation exacerbated thyroid autoimmunity in
NOD-H2h4 mice, as demonstrated by the elevated thyroiditis scores and
anti-Tg autoantibody titers. Only one-time low-dose irradiation could
exacerbate the pathology of HT, which was different from reports con-
cerning repeated low-dose irradiation by Fang et al. (2005, 2006). Low-
dose whole-body γ-irradiation may have a systemic effect on this disease
even if the frequency of irradiation is only once.
There were no data concerning Treg cells in the above three reports;
however, the Treg population in asthma mice model was recently report-
ed by Park et al. (2013a). They showed the Treg cell population was high-
er in irradiated OVA mice than in OVA or control mice. They suggested
that Treg cells enhancement/migration by irradiation may exert a sup-
pressive function in airway inflammation and tissue remodeling in allergic
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asthma. Their irradiation protocol of Park et al. (2013a) (Fig. 7) was com-
pletely different from that of Fang et al. (2005) (Fig. 5A) or Park et al.
(2013b) (Fig. 5B). They firstly sensitized mice twice with OVA on day 1 and
day 15, and after sensitization, mice received whole-body 0.667Gy
(4.72Gy/min) γ-irradiation once daily for 3 consecutive days 24 h before
each challenge. If one wants to examine the effect of irradiation on the
existing immune condition, the schedule for sensitization and challenge
with OVA and irradiation conducted by Park et al. (2013a) is perfect fit as
they first induced the disease and then started the irradiation (Fig. 7).
Total radiation dose of the work by Park et al. (2013a) was 2Gy (Fig. 7),
whereas those of Fang et al.(2005) and Park et al.(2013b) were 5Gy (Figs.
5A and 5B). Although there are few data about asthma other than the
above three reports, irradiation schedules and doses seem to be reason-
able because they were intermediate levels between the local irradiation
doses to arthritic joints in animal model that reported by Hildebrandt et
al. (2000) and clinical therapy doses reported by Liebmann et al. (2004).
In our referenced papers, smaller total irradiation dose might be good for
attenuation of disease. Moreover, higher Treg cell population after irradi-
ation might help attenuate allergic asthma as well as the phenomenon that
were seen in CIA (Table 2E). Meanwhile, the sensitivity to irradiation may
be strain-dependent. Shankar et al. (1999) indicated that the modification
of immune response by radiation was different between BALB/c and
C57BL/6 mice. Park et al. (2013b) and Park et al. (2013a) used C57BL/6
mice, on the other hand, Fang et al. (2005) used BALB/c mice. In their
result, although the total irradiation doses were different, the attenuation
might be seen when the induction of disease was firstly conducted and
then irradiation was administered after that (Figs. 5A and 7). On the other
hand, the exacerbation might be seen when the irradiation was firstly
administered and then the induction of disease was conducted (Fig. 5B).
As this difference may be caused by the irradiation protocol, total irradia-
tion dose or animal strain, further examinations are needed to elucidate
whether this phenomenon can be applied to therapy.
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Expected mechanisms of pathological improvement or exacerbation of dis-
eases.
According to our referenced papers, it is clear that the low dose frac-
tionated irradiation lowered IL-6 levels that were high in CIA or EAE
mice (Tables 2B and 4) and up-regulated Treg cells in CIA mice (Table
2E). This phenomenon could be preferable to attenuation of autoim-
mune diseases such as CIA or EAE. In SLE, it is clear that abnormal
CD3+CD4-CD8-B220+ cells were lowered by low-dose fractionated irradia-
tion (Table 3A). The phenomenon could be preferable to attenuation of
SLE. In exacerbated cases, low-dose fractionated irradiation lowered
IFN-γ levels that were high in asthma mice (Table 6A) and up-regulated
CD4+ cells in AD or asthma mice (Tables 5B and 6B). The phenomenon
could be the evidence of exacerbation of diseases. However, these were
events after irradiation; therefore any other mechanisms have not been
elucidated.
However, the results of these animal studies may provide useful infor-
mation about the mechanism and evidence of LD-RT that has been
empirically performed for a long time. The information in this review is
worth considering together with that of the review article of Rödel et al.
(2007, 2012) when the LD-RT is conducted.
CONCLUSION
From the referenced studies, the effect of low-dose γ-irradiation was
shown to be different depending on the cause of the immunological dis-
ease. If the cause is due to an antibody against an internal antigen, for
example, CIA, SLE, and MS, which are generally referred to as autoim-
mune diseases, the effect of low-dose irradiation may be preferable. In
contrast, if the cause is due to an external antigen, for example, AD and
asthma, which are generally referred to as allergic diseases, the effect of
low-dose irradiation may be unfavorable.
The effect of low-dose γ-irradiation may be the attenuation or exac-
erbation of pathologies depending on the source of the antigen causing
the disease. Therefore, the cause should be taken into consideration
when low-dose γ-irradiation is used as a therapy for immunological dis-
eases.
In conclusion, LD-RT could be clinically applied for RA, SLE and MS
from our referenced animal study papers because the irradiation reduces
IL-6 levels, up-regulates Treg cells in CIA or down-regulate abnormal cells
which are characteristic to SLE. On the other hand, it may be difficult for
clinical application of LD-RT in AD or asthma because IF-γ level was low-
ered by irradiation in asthma and up-regulation of CD4+ cells were
observed by irradiation in AD or asthma mice.
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